1. Kroft,S.H. and Oyasu,R. ( 1994 ) Urinary bladder cancer: mechanisms of development and progression. Lab. Invest. , 71 , 158 –174.
2. Harnden,P., Mahmood,N. and Southgate,J. ( 1999 ) Expression of cytokeratin 20 redefines urothelial papillomas of the bladder. Lancet , 353 , 974 –977.
3. Cote,R.J. and Datar,R.H. ( 2003 ) Therapeutic approaches to bladder cancer: identifying targets and mechanisms. Crit. Rev. Oncol. Hematol. , 46 (Suppl.), S67 –S83.
4. Spruck,C.H.,III, Ohneseit,P.F., Gonzalez-Zulueta,M., Esrig,D., Miyao,N., Tsai,Y.C., Lerner,S.P., Schmutte,C., Yang,A.S., Cote,R. et al . ( 1994 ) Two molecular pathways to transitional cell carcinoma of the bladder. Cancer Res. , 54 , 784 –788.
5. Pollack,A., Czerniak,B., Zagars,G.K., Hu,S.X., Wu,C.S., Dinney,C.P., Chyle,V. and Benedict,W.F. ( 1997 ) Retinoblastoma protein expression and radiation response in muscle-invasive bladder cancer. Int. J. Radiat. Oncol. Biol. Phys. , 39 , 687 –695.